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Few studies have defined how the risk of hospital-acquired
acute renal failure varies with the level of estimated
glomerular filtration rate (GFR). It is also not clear whether
common factors such as diabetes mellitus, hypertension and
proteinuria increase the risk of nosocomial acute renal failure
independent of GFR. To determine this we compared 1,746
hospitalized adult members of Kaiser Permanente Northern
California who developed dialysis-requiring acute renal
failure with 600,820 hospitalized members who did not.
Patient GFR was estimated from the most recent outpatient
serum creatinine measurement prior to admission. The
adjusted odds ratios were significantly and progressively
elevated from 1.95 to 40.07 for stage 3 through stage 5
patients (not yet on maintenance dialysis) compared to
patients with estimated GFR in the stage 1 and 2 range.
Similar associations were seen after controlling for inpatient
risk factors. Pre-admission baseline diabetes mellitus,
diagnosed hypertension and known proteinuria were also
independent risk factors for acute kidney failure. Our study
shows that the propensity to develop in-hospital acute
kidney failure is another complication of chronic kidney
disease whose risk markedly increases even in the upper half
of stage 3 estimated GFR. Several common risk factors for
chronic kidney disease also increase the peril of nosocomial
acute kidney failure.
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Acute renal failure (ARF; also known as ‘acute kidney injury’)
is among the most important complications observed in
hospitalized patients. When severe enough to require dialysis,
ARF is associated with a high rate of in-hospital mortality
(exceeding 30%).1,2 Even modest declines in kidney function
have been associated with a significantly heightened risk of
death, prolonged length of stay, and increased costs.3,4 Several
recently published studies have suggested that the incidence
of ARF has increased dramatically over the past two
decades.2,5 Several studies have attempted to identify
determinants of ARF, but most have focused on hospital-
based or intensive care unit-based risk factors6–9 and results
have been inconsistent.1,10,11
Existing kidney disease (that is, chronic kidney disease)
appears to be among the most potent predictors of acute
declines in kidney function following exposure to radio-
contrast,12 major surgery,13 and other medical conditions.6
However, a common limitation in prior studies is to
use serum creatinine concentrations obtained at admission
to the hospital or intensive care unit to indicate underlying
kidney function. This would bias risk estimation if
these serum creatinine concentrations represented early
acute kidney injury rather than true baseline kidney function.
Few studies have incorporated preadmission outpatient or
other steady-state serum creatinine measurements in
studies of hospital-acquired ARF. Moreover, the degree to
which impaired kidney function renders persons at risk
for ARF episodes independent of other disease states
and procedures performed in hospital has not been
established.
We hypothesized that severity of baseline kidney function
impairment would be strongly associated with risk of
hospital-acquired ARF, and this would be independent of
other demographic factors and comorbid conditions. We
hypothesized that the increase in risk of ARF—like other
adverse consequences of chronic kidney disease—would be
evident below an estimated glomerular filtration rate (GFR)
of 60 ml per min per 1.73 m2 and become stronger with
progressively worse renal function. We further hypothesized
that common risk factors for chronic kidney disease—such as
diabetes mellitus, hypertension, and proteinuria—are also
risk factors for ARF and at similar estimated GFR level,
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patients with diabetes mellitus would be at higher risk of ARF
compared with their counterparts without.
RESULTS
From 1996 to 2003, a total of 1764 Kaiser members developed
hospital-acquired ARF treated with dialysis. These patients
were compared with 600 820 members who were hospitalized
but did not develop ARF requiring dialysis. All cases and
controls had outpatient serum creatinine measurements prior
to hospitalization.
A review of medical records among a random sample of
100 subjects classified as having dialysis-requiring ARF and
baseline estimated GFR of X45 ml per min per 1.73 m2
showed that all had ARF and received acute dialysis. A review
of medical records among a random sample of 100 subjects
classified as having dialysis-requiring ARF and baseline GFR
o45 ml per min per 1.73 m2 showed that all had ARF and 99
received acute dialysis. In one instance, acute dialysis was
initially planned but not performed and the patient died.
There were no observed cases of elective hospitalization for
initiation of chronic maintenance dialysis.
Compared with those who did not develop dialysis-
requiring ARF, those who did were older and more likely to
have baseline diabetes mellitus, hypertension, and proteinuria
(Table 1), and they had on average worse renal function
(Table 2). Patients who developed ARF were also more likely
to have had an intensive care unit stay, to require mechanical
ventilation, and to suffer from sepsis and hyperbilirubinemia
(Table 1).
Relation with baseline GFR
The median duration of time between last outpatient
estimated GFR and admission was 83 days (interquartile
range: 6–312). Baseline estimated GFR was a very strong risk
factor for ARF. Overall, of the 1746 cases of dialysis-requiring
ARF, 1295 (74%) occurred among those with baseline
estimated GFR of o60 ml per min per 1.73 m2 (Table 2).
After adjusting for age, sex, race/ethnicity, and also other
baseline conditions, there remained a strong graded relation-
ship between risk of ARF and baseline estimated GFR. Even
subjects with estimated GFR of 45–59 ml per min per 1.73 m2
had a twofold increase in adjusted odds ratio of ARF
compared with subjects with estimated GFR of 60 ml per min
per 1.73 m2 or higher. The risk then increases sharply for
increasing severity of baseline kidney disease (Table 3).
Further adjustment for in-patient risk factors for ARF—
including hyperbilirubinemia, intensive care unit stay, sepsis,
mechanical ventilation, cardiac surgery, and cardiac cathe-
terization—did not significantly alter the association between
baseline estimated GFR and risk of ARF (Table 3).
Several sensitivity analyses were undertaken. Similar
results were seen when we excluded patients whose last
observed outpatient GFR was more that 12 months or less
than 30 days before hospital admission (Table 4). Similar
results were seen when we further required that subjects have
a second outpatient GFR reading in the same GFR category
as the latest outpatient GFR reading (Table 4) or when we
controlled for baseline chronic heart failure and chronic liver
disease (data not shown).
Other clinical risk factors for ARF
Baseline diabetes mellitus, diagnosed hypertension, and
documented proteinuria were independent risk factors for
ARF in multivariable models adjusted for age, sex, race/
ethnicity, and estimated GFR (Table 3).
For the GFR categories of 45–59 ml per min per 1.73 m2
and 30–44 ml per min per 1.73 m2, there were statistically
significant interactions between diabetes mellitus and severity
of chronic kidney disease with regard to risk of ARF (P¼ 0.01
and 0.04, respectively). Patients with diabetes mellitus were at
higher risk for ARF compared with their counterparts
Table 1 | Characteristics of subjects who did and did not














Women, n (%) 735 (41.7%) 340 940 (56.8 %)
Race/ethnicity
White/European 1086 (61.6%) 385 314 (64.1%)
Black/African
American
251 (14.2%) 48 257 (8.0%)
Hispanic 147 (8.3%) 41 194 (6.9%)
Asian/Pacific Islander 167 (9.5%) 55 778 (9.3%)
Native American/
Mixed
101 (5.7%) 30 369 (5.1%)
Unknown 12 (0.7%) 39 908 (6.6%)
Selected medical history
Diabetes mellitus 851 (48.2%) 87 133 (14.5%)
Diagnosed
hypertension
1268 (71.9%) 221 422 (36.9%)
Documented
proteinuria
969 (54.9%) 65 679 (10.9%)
Chronic heart failure 809 (45.9%) 31 754 (5.3%)
Chronic liver disease 111 (6.3%) 10 903 (1.8%)
Index hospitalization features
Hyperbilirubinemia 347 (19.7%) 6419 (1.1%)
Intensive care unit
stay
1101 (62.4%) 34 077 (5.7%)
Sepsis 488 (27.7%) 6879 (1.1%)
Mechanical
ventilation





127 (7.2%) 24 024 (4.0%)
Percutaneous
coronary intervention
31 (1.8%) 4491 (0.8%)
Coronary artery
bypass graft surgery
52 (2.9%) 3144 (0.5%)
Other cardiac surgery 39 (2.2%) 650 (0.1%)
ARF, acute renal failure.
P-value for all comparisons o0.0001.
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Table 2 | Baseline renal function before hospitalization among case and control subjects.
Cases who developed ARF (N=1764) Controls who did not develop ARF (N=600 820)
Last observed outpatient serum




estimated GFR (mean±s.d.), ml
per min per 1.73 m2
43.5±30.7 74.2±21.3
Last observed outpatient
estimated GFR, ml per min per
1.73 m2
Median (interquartile range) duration between
admission and last known outpatient estimated
GFR before hospitalization (in days)
Median (interquartile range) duration between
admission and last known outpatient estimated
GFR before hospitalization (in days)
X60 N=469 79 (15, 294) N=464 720 98 (7, 346)
45–59 N=234 35 (4, 149) N=97 356 67 (6, 250)
30–44 N=294 25 (4, 110) N=28 434 25 (2, 135)
15–29 N=476 17 (3, 51) N=7763 6 (1, 49)
o15 not requiring dialysis N=291 13 (3, 40) N=2547 2 (1, 9)
ARF, acute renal failure; GFR, glomerular filtration rate.





Multivariablea odds ratio after adjusting for
in-patient risk factorsb for ARF
(95% confidence interval)
Baseline GFR (ml per min per 1.73 m2)
X60 Reference Reference Reference
45–59 2.38 (2.04–2.79) 1.95 (1.66–2.30) 1.66 (1.40–1.97)
30–44 10.25 (8.85–11.86) 6.54 (5.57–7.69) 4.75 (4.01–5.63)
15–29 60.76 (53.38–69.16) 28.50 (24.50–33.14) 20.42 (17.40–23.96)
o15 113.21 (97.31–131.71) 40.07 (33.75–47.58) 47.17 (39.22–56.74)
Diabetes mellitus 5.50 (5.00–6.04) 2.07 (1.86–2.30) 1.99 (1.78–2.23)
Diagnosed hypertension 4.38 (3.95–4.86) 1.41 (1.25–1.58) 1.55 (1.37–1.76)
Documented proteinuria 9.93 (9.04–10.91) 2.79 (2.49–3.11) 2.84 (2.52–3.19)
ARF, acute renal failure; GFR, glomerular filtration rate.
aAdjusted for all variables shown and also age, sex, and race/ethnicity.
bFurther adjusted for hyperbilirubinemia, intensive care unit stay, sepsis, receipt of mechanical ventilation, coronary artery bypass surgery, other cardiac surgery,
percutaneous coronary intervention, and cardiac catheterization including intravenous contrast.
Table 4 | Sensitivity analyses for assessment of risk factors for dialysis-requiring acute renal failure
Multivariablea odds ratio (95% confidence interval)
After excluding those with outpatient
estimated GFR41 year before
hospitalization
After excluding those with
outpatient estimated GFR41 year
or o30 days before
hospitalization
Among subset of subjects
with 1 outpatient estimated GFR
measured 1–12 months before
hospitalization
and who had a prior estimated GFR
in the same stage
Baseline estimated GFR (ml per min per 1.73 m2)
X60 Reference Reference Reference
45–59 2.13 (1.79–2.54) 1.96 (1.53–2.51) 2.03 (1.43–2.90)
30–44 6.80 (5.73–8.07) 6.57 (5.10–8.47) 8.48 (6.12–11.74)
15–29 28.99 (24.72–34.00) 30.44 (23.70–39.11) 42.63 (31.46–57.76)
o15 40.03 (33.46–47.90) 80.37 (58.47–110.46) 107.12 (73.18-156.84)
Diabetes mellitus 2.06 (1.85–2.30) 2.08 (1.75–2.47) 1.88 (1.52–2.33)
Diagnosed
hypertension
1.37 (1.21–1.55) 1.52 (1.25–1.86) 1.21 (0.95–1.56)
Documented
proteinuria
2.77 (2.46–3.11) 2.89 (2.41–3.47) 2.22 (1.76–2.81)
GFR, glomerular filtration rate.
aAdjusted for all variables shown and also age, sex, and race/ethnicity.
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without diabetes mellitus in the same GFR category. Similar
trends were seen among patients with GFR 15–29 ml per min
per 1.73 m2 and o15 ml per min per 1.73 m2, although the
interactions were not statistically significant. Because of this,
we repeated our logistic regression model stratified by
diabetes status, and Figure 1 shows the separate adjusted
odds ratios for subjects with and without diabetes.
DISCUSSION
Although ARF is one of the most common renal problems
encountered among hospitalized patients, there is a paucity
of research about its epidemiology and risk factors. For
example, only recently has the incidence of ARF been
determined using representative populations.2,5 A recent
American Society of Nephrology Renal Research report
identified better understanding of risk factors for ARF as a
top research priority.14
Although baseline renal insufficiency is known to be a risk
factor for ARF, few studies actually quantified the association
between the level of preexisting kidney function and
subsequent risk of ARF. Many prior studies used arbitrary
dichotomous cutoffs to define ‘normal’ or ‘abnormal’
baseline renal function (for example, above or below serum
creatinine of 1.2 mg per 100 ml8 or above or below
150 mmol/l1 (Parfrey et al.).12 None to our knowledge has
used the consensus National Kidney Foundation Chronic
Kidney Disease staging system. In addition, previous studies
often did not explicitly delineate how ‘baseline’ kidney
function was determined. In many cases, serum creatinine
concentrations observed only during the index hospitaliza-
tion were used.7,8 Serum creatinine values in the hospital may
be higher than actual baseline (usual) values because of
incipient ARF or they may be lower because of acute events
such as blood loss, volume resuscitation, and hemodilution.4
Past studies have also been limited because of inclusion of
only one type of ARF15,16 or underrepresentation of women
and racial/ethnic minorities.17
The current study contributes to the literature in several
important ways. We studied a large, diverse population and
did not limit the type of ARF. We focused on ARF requiring
dialysis, which is known to be associated with very high risk
of mortality and morbidity. Careful attention was given in
defining ‘baseline’ kidney function using calibrated pre-
admission outpatient measurements of serum creatinine and
the Modification of Diet in Renal Disease (MDRD) equation.
The comprehensive clinical information in the Kaiser
databases also allowed us to capture important comorbid
conditions preceding and coincident with hospitalization.
Our large study sample was diverse in terms of race/ethnicity
and included both men and women across a wide age range.
We found that an increase in risk of ARF becomes
apparent starting below an estimated GFR of 60 ml per min
per 1.73 m2. Even subjects with estimated GFR of 45–59 ml
per min per 1.73 m2 have on average a twofold increased in
adjusted odds ratio of ARF compared with subjects
with estimated GFR of 60 ml per min per 1.73 m2 or
above—with risk being higher among subjects with diabetes
than those without. We believe that rigorously quantifying
risk of ARF in the large number of patients with milder stage
‘3a’ chronic kidney disease is an important contribution of
this study. This threshold is consistent with prior research
showing that several other adverse consequences of chronic
kidney disease, such increase in risk of cardiovascular disease
and anemia, also become apparent below an estimated GFR
of 60 ml per min per 1.73 m2.18–20 These data support the
National Kidney Foundation Chronic Kidney Disease Guide-
lines in which persons with GFR chronically below 60 ml per
min per 1.73 m2 are classified as having chronic kidney
disease, regardless of other factors.
Relatively little attention has been paid to the relationship
between severity of chronic kidney disease and risk of ARF.
For example, National Kidney Foundation Clinical Practice
Guidelines for Chronic Kidney Disease devoted specific
chapters to discuss the association of level of GFR with
hypertension, anemia, nutritional status, bone and mineral
metabolism disease, neuropathy, and indices of functioning
and well being.21 But there is no discussion on the association
of level of GFR with ARF. In fact, the magnitude of the
increase in odds ratio of ARF with progressively more severe
chronic kidney disease—up to 20- or 30-fold higher adjusted
risk – underscores the fact that ARF may in fact be the one
adverse sequela of chronic kidney disease most tightly linked
with estimated GFR.
Better quantification of the impact of baseline kidney
function on risk of ARF should lead to improved risk
stratification and clinical decision making regarding whether
or not to proceed with interventions that may predispose to
ARF or adopt preventive measures to reduce ARF risk.
Beyond direct patient care issues, these data have impli-
cations for the design of future studies of ARF. The fact that
most cases of ARF occur among those with some degree of
reduced renal function means that ARF trials (some of which
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Figure 1 | Multivariable association of baseline estimated GFR
and dialysis-requiring ARF stratified by the presence or
absence of diabetes mellitus (DM). Each model adjusted for
age, sex, race/ethnicity, diagnosed hypertension, and
documented proteinuria.
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‘baseline’ serum creatinine22,23) should be more inclusive of
those with preexisting chronic kidney disease to be more
generalizable. These data also highlight the need for more
epidemiology studies to understand the potential impact of
episodes of ARF on the course of chronic kidney disease in
addition to focusing on the impact of ARF on those with
normal renal function.24
Our study also indicated that another marker for chronic
kidney disease—proteinuria—is an important independent
risk factor for ARF. Patients with documented dipstick
proteinuria appear to be two to three times as likely as
patients without this to develop ARF, independent of
estimated GFR. It is possible that patients with proteinur-
ia—similar to those with chronically low GFR—have less
physiological adaptability and are therefore less able to
tolerate reduced renal blood flow and other nephrotoxic
insults.
We found that two major risk factors for chronic kidney
disease—hypertension and diabetes—also were risk factors
for development of ARF. Few studies have investigated
hypertension as a risk factor for ARF.25 Diabetes has been
recognized as a risk factor for contrast nephropathy12 and
other types of ARF.15,16 We noted an important interaction
between presence of diabetes and risk of ARF. Within the
same estimated GFR category, patients with diabetes appear
to have higher risk of ARF than their counterparts without.
This interaction had been well-known for one particularly
subtype of ARF—contrast nephropathy12—but our study
show that this interaction seems generalizable to other causes
of dialysis-requiring ARF.
Limitations of this study include the fact that we did not
study hospitalized patients without serum creatinine deter-
minations before admission. We may have missed cases of
dialysis-requiring ARF, as it was not feasible to review
medical records of all cases. However, recent data show that
administrative codes for dialysis-requiring ARF have a
sensitivity of over 90%.26 Baseline renal function was not
measured but rather estimated using the MDRD equation. As
a result of the known limitations of the MDRD equation, we
did not report estimated GFR levels above 60 ml per min per
1.73 m2. It was also not possible to have assessments of renal
function on all subjects at a fixed time point prior to the
development of ARF, because the occurrence of ARF is
usually unpredictable. However, our sensitivity analysis
suggests that this does not appear to be an important source
of bias. Our definition of ARF may be considered arbitrary
but there is no commonly accepted definition of ARF and the
X50% increase in serum creatinine requirement fits the
recently proposed Acute Kidney Injury Network’s diagnostic
criteria for acute kidney injury.27 Among patients with very
advanced chronic kidney disease, it may be difficult to
distinguish between the final stages of progression to end-
stage renal disease from potentially reversible acute-on-
chronic renal failure so the very high odds ratio observed
among those with estimated GFR of o15 ml per min per
1.73 m2 must be interpreted with caution. We did not have
direct measures of blood pressure and relied on physician-
assigned codes to ascertain hypertension. Proteinuria was
analyzed as a dichotomous variable and assessed only by
dipstick urinalysis among those who had this test done as
part of routine clinical care. However, misclassification would
generally tend to bias toward the null and so the underlying
associations between ARF and hypertension or proteinuria
may be stronger than what we observed. As our study was
conducted among insured members of a northern California
integrated healthcare delivery system, our results may not be
completely generalizable to other populations.
In conclusion, a heightened risk of ARF is another adverse
sequela of chronic kidney disease that becomes apparent at an
estimated GFR of below 60 ml per min per 1.73 m2. Even
subjects with estimated GFR 45–59 ml per min per 1.73 m2
had a twofold increase in adjusted odds ratio of ARF
compared with subjects with estimated GFR 60 ml per min
per 1.73 m2 or above. This study is distinguished from prior
investigations of ARF that have mostly focused on hospital-
based or intensive care unit-based risk factors. By clearly
delineating the baseline kidney function against which the
risk of ARF is defined, we rigorously quantified the strength
of this important clinical relation. The large odds ratios
observed support the notion that underlying chronic kidney
disease is the single most important risk factor for ARF.
Given that ARF is associated with high mortality rates, ARF
may be another mechanism contributing to the high
mortality rates observed among patients with chronic kidney
disease. Our results suggest that other markers of chronic
kidney disease—such as proteinuria—and other risk factors
for chronic kidney disease—such as hypertension and
diabetes—are also risk factors for ARF.
MATERIALS AND METHODS
Study population
We studied adult members (X20 years old) enrolled in Kaiser
Permanente of Northern California (Kaiser), a large integrated
healthcare delivery system currently insuring more than one-third of
the San Francisco Bay Area adult population. Its population is
representative of local surrounding and statewide populations with
only slightly lower-than-population percentages at the extremes of
the socioeconomic spectrum and age.28 We included in the source
population all adults who had one or more outpatient determina-
tions of serum creatinine between 1996 and 2003.20
Identification of dialysis-requiring acute renal failure
We focused in this study on cases of dialysis-requiring ARF, which is
known to be associated with high rates of morbidity and mortality.
All analyses excluded patients who received a prior kidney transplant
or were on maintenance dialysis. We cross-linked our study
population with the nationally comprehensive US Renal Data
System (USRDS) registry. At the time of cross-linkage, USRDS data
were complete through 31 December 2003. Supplementary deter-
mination of end-stage renal disease status was performed using data
from an internal Kaiser end-stage renal disease registry.29
Cases of dialysis-requiring ARF were identified among hospita-
lized patients who had outpatient measures of serum creatinine
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prior to admission and who were not already on maintenance
dialysis. ARF requiring dialysis was defined as peak in-patient serum
creatinine greater than last observed preadmission outpatient serum
creatinine by X50% and receipt of dialysis during hospitalization.
International Classification of Disease, Ninth Edition (ICD-9)
procedure codes 54.98 and 39.95 and Current Procedural Terminol-
ogy (CPT) codes 90935, 90937, 90945, 90947, and 90999 were used
to identify episodes of acute peritoneal dialysis hemodialysis
hemofiltration from health plan hospital discharge databases. A
board-certified nephrologist validated this approach by auditing the
charts of 200 randomly selected patients meeting the ARF definition.
Only the first hospitalization for each subject during the study
period was considered. Control subjects included all patients who
were hospitalized but did not develop dialysis-requiring ARF and
who had outpatient serum creatinine measurements prior to
admission.
Assessment of baseline serum creatinine and estimated
glomerular filtration rate
Glomerular filtration rate was estimated from serum creatinine and
the abbreviated MDRD equation.21,30 Measurement of serum
creatinine by the Kaiser regional health plan laboratory was
calibrated against the MDRD core laboratory,20 which allowed for
a more reliable estimate of GFR.31,32 Baseline GFR was estimated
from serum creatinine determinations not associated with hospitali-
zations to better reflect baseline kidney function. Baseline kidney
function was defined as the last outpatient GFR before admission.
Assessment of other exposures of interest
Outpatient covariates were assessed as previously described using
comprehensive laboratory, prescription medication, and diagnostic
code data.20 These included age, sex, race/ethnicity, diabetes
mellitus,20,29 diagnosed hypertension (by ICD-9 codes 401–405),20
and documented proteinuria. Documented proteinuria was based
on laboratory database entries of urine protein dipstick results of
1þ or greater (approximately 30 mg per 100 ml or greater) in the
absence of a possible urinary tract infection (that is, concomitant
positive test for urinary nitrite or esterase).20
To capture important in-hospital complications associated with
ARF, we determined the need for mechanical ventilation using ICD-9
code 96.7x33–35 and the presence of sepsis using ICD-9 codes 38.xx,
020.0, 790.7, 117.9, 112.5, 112.81.33 Hyperbilirubinemia was defined
as observed peak in-patient serum total bilirubin level 42.0 mg per
100 ml. Intensive care unit stay was determined using hospitalization
administrative records. Cases of coronary artery bypass surgery,
other cardiac surgery, percutaneous coronary intervention, and
diagnostic cardiac catheterization involving intravenous contrast
were identified using relevant procedure codes (listed in Appendix).
Statistical analysis
For this nested case–control study, we used a logistic regression
model with dialysis-requiring ARF as the outcome and baseline
kidney function as the main exposure of interest. The predictor
variable estimated GFR was categorized using a modified National
Kidney Foundation classification of chronic kidney disease: X60 ml
per min per 1.73 m2 (reference group), 45–59 ml per min per 1.73 m2
(stage 3a), 30–44 ml per min per 1.73 m2 (stage 3b), 15–29 ml per
min per 1.73 m2 (stage 4), and o15 ml per min per 1.73 m2 not
requiring dialysis (stage 5). Area under the receiver operating
characteristic curve for the main result multivariable analysis was
0.84, indicating good model fit. The Hosmer–Lemeshow test w2 was
19.07, P¼ 0.014, indicating very mild departures from perfect
model fit for a sample of this size.
Interaction terms between GFR and diabetes were tested based
on our a priori consideration that the threshold for increased ARF
risk by GFR might vary by diabetes status.12 Given the significant
interaction, we presented models stratified by diabetes status.
In sensitivity analyses, we excluded patients whose last observed
outpatient GFR was more that 12 months before the hospitalization
to reduce misclassification of baseline kidney function. We also
additionally excluded patients whose last observed outpatient GFR
was less than 30 days before the hospitalization as the decline in GFR
observed shortly before hospitalization may be part of the acute
illness that led to hospitalization. Finally, we repeated our multi-
variate model among the subset of patients with at least one
outpatient GFR estimated 1–12 months prior to hospitalization and
who also had a second earlier GFR that was in the same GFR
category/chronic kidney disease stage (for example, if the most
recent estimated GFR prior to hospitalization was between 30–44 ml
per min per 1.73 m2, then one before that would also have to be
between 30–44 ml per min per 1.73 m2).
We considered two-tailed P-values o0.05 to be statistically
significant. Analyses were conducted using SAS (Cary, NC, USA).
The institutional review boards of collaborating institutions
approved the study. Waiver of informed consent was obtained
because of the nature of the study.
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